RCT snapshots vs. Real World Evidence treatment pathway
26 September 2019
- RWE can provide insight on an entire treatment pathway, whereas an RCT can typically only focus on a single line.
- This evidence may be used to:
- aid in the refinement of patient care and clinical pathway design
- overcome data gaps
- inform clinical decision-making
- support RCT data in licensing and market authorisation applications
Click here to find out more
About SVMPharma
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com